
KYRNF
Healthcare · Drug Manufacturers - Specialty & Generic · $592.3M market cap
$10.310.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jul 30, 2026 | After the close | — | 0.09 | — |
| Feb 4, 2026 | After the close | — | 0.30 | — |
| Jul 31, 2025 | After the close | — | 0.25 | — |
| Feb 5, 2025 | Before the open | — | 0.14 | — |
| Nov 7, 2024 | Before the open | — | 0.04 | — |
| Jul 31, 2024 | Before the open | — | 0.10 | — |
KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells generic drugs in Japan and internationally. The company is also involved in drug discovery and licensing activities. It also offers infectious disease-related products; over-the-counter drug; and generic drugs. The company was formerly known as KYORIN Holdings, Inc. KYORIN Pharmaceutical Co., Ltd. was founded…